Biologics Outsourcing Market Size, Regional Overview, Competitive Landscape, Business Growth, Share Analysis And Forecast To 2033

"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Biologics Outsourcing Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $33.29 billion In 2028 At A CAGR Of 13.1%.

The biologics outsourcing market size has grown rapidly in recent years. It will grow from $17.74 billion in 2023 to $20.33 billion in 2024 at a compound annual growth rate (CAGR) of 14.6%. The growth in the historic period can be attributed to increasing r&d costs, regulatory pressure, demand for specialized expertise, globalization.

The biologics outsourcing market size is expected to see rapid growth in the next few years. It will grow to $33.29 billion in 2028 at a compound annual growth rate (CAGR) of 13.1%. The growth in the forecast period can be attributed to emerging markets' growth, personalized medicine, strategic alliances, biological drug patent expirations. Major trends in the forecast period include advancements in technology, increased outsourcing complexity, biosimilars market expansion, data analytics integration, supply chain resilience.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=12573&type=smp

Biologics Outsourcing Market Major Segments
The biologics outsourcing market covered in this report is segmented -

1) By Product Type: Antibodies, Recombinant, Vaccines, Protein, Other Products
2) By Source: Human, Microbial, Other Source
3) By Application: Oncology, Cellular and Gene Therapy, Blood And Blood-Related Products Development, Vaccine Development, Stem Cell Research, Other Applications
4) By End User: Pharmaceutical Industries, Biotechnology Industries, Contract Development And Manufacturing Organization(CDMO)

Key Driver - Surge In Cancer Cases Fuels Biologics Outsourcing Market Growth

The rising number of cancer cases is expected to propel the growth of the biologics outsourcing market going forward. Cancer is a broad category of illnesses that can develop in nearly any organ or tissue in the body when aberrant cells proliferate uncontrollably, cross their usual boundaries, and either spread to other organs or invade neighboring body parts. Biologics outsourcing plays a significant role in cancer cases by providing specialized expertise, resources, and infrastructure for the development, manufacturing, and clinical supply of biologic therapies, including monoclonal antibodies, immunotherapies, and other targeted biologics that are used for the diagnosis, treatment, and management of various types of cancer. For instance, in January 2023, according to the National Center for Biotechnology Information, a US-based intergovernmental organization, there were 1,958,310 new cancer cases in the United States, and 609,820 cancer deaths are projected to occur in 2023. Further, the number of new cancer cases per year is expected to rise to 29.5 million and the number of cancer-related deaths to 16.4 million by 2040. Therefore, the rising number of cancer cases is driving the growth of the biologics outsourcing market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=12573&type=smp

Prominent Trend - Developments In Biologics And Strategic Partnerships Transforming The Biologics Outsourcing Market

Developments in biologics are a key trend gaining popularity in the biologics outsourcing market. Major companies operating in the biologics outsourcing market are adopting new technologies to sustain their position in the market. For instance, in February 2022, Abzena, a US-based contract development and manufacturing organization (CDMO), Alira Health, a US-based healthcare firm, and Oncodesign, a France-based biopharmaceutical company, launched DRIVE-Biologics, a consortium designed for biologic drug discovery and development programs. This provides integrated solutions with specialist services, from biological discovery to clinical and commercial manufacturing. This partnership, which combines industry leadership in fields such as design and developability, proof of concept in preclinical pharmacology and pharmaco-imaging, toxicology, and clinical design through commercial manufacturing, would streamline information sharing and program deliverables to help de-risk biologics development. Additionally, partners would have access to expertise at all drug discovery and development stages, including design, preclinical, clinical, and CMC (chemistry, manufacturing, and control).

Biologics Outsourcing Market Players
Major companies operating in the biologics outsourcing market report are AbbVie Inc., Thermo Fisher Scientific Inc., Boehringer Ingelheim GmbH, Lonza Group Ag, Catalent Inc., Sartorius Stedim Biotech S.A., Charles River Laboratories International Inc., WuXi Biologics Inc., Samsung Biologics Co. Ltd., Emergent BioSolutions Inc., CordenPharma GmbH, Ajinomoto Bio-Pharma Services, Syngene International Limited, Rentschler Biopharma SE, Albany Molecular Research Inc., KBI Biopharma Inc., Fujifilm Diosynth Biotechnologies Inc., Avid Bioservices Inc., BioVectra Inc., ProBioGen AG, ABL Inc., Vibalogics GmbH, JHL Biotech Inc., Goodwin Biotechnology Inc., Crown Bioscience Inc., Cytovance Biologics Inc., LakePharma Inc., AGC Biologics GmbH, Biomay AG, Polpharma Biologics S.A.

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/biologics-outsourcing-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the biologics outsourcing market in 2023. The regions covered in the biologics outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Biologics Outsourcing Market Report Structure
3. Biologics Outsourcing Market Trends And Strategies
4. Biologics Outsourcing Market - Macro Economic Scenario
5. Biologics Outsourcing Market Size And Growth
…..
27. Biologics Outsourcing Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.